Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 28: 642-645, 1982;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haidukewych, D.
Right arrow Articles by Sills, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haidukewych, D.
Right arrow Articles by Sills, M.

Clinical Chemistry, Vol 28, 642-645, Copyright © 1982 by American Association for Clinical Chemistry

Monitoring octanoic and decanoic acids in plasma from children with intractable epilepsy treated with medium-chain triglyceride diet

D Haidukewych, WI Forsythe and M Sills

We describe a procedure for gas-chromatographic determination of n- octanoic and n-decanoic acids in 100 microL of plasma from children with intractable epilepsy treated with medium-chain triglyceride (MCT) diet. With n-nonanoic acid as the internal standard, the extraction efficiencies for octanoic and decanoic acids were 98 and 105%, respectively. Within-run CVs for octanoic acid at 0.5, 1.0, 2.5, 5.0, 7.5, and 10.0 micrograms/0.1 mL were 8.8, 7.9, 8.5, 6.5, 4.3, and 5.7%, respectively. For decanoic acid at identical concentrations, the CVs were 10.0, 7.4, 4.9, 4.0, 2.6, and 3.5%, respectively. For 10 children on MCT diet (45.9% of calories supplied as MCT) the mean concentrations of octanoic and decanoic acids were 44.2 and 27.0 mg/L, respectively. Presence of relatively "high" quantities of these acids in plasma may contribute to seizure control when MCT diet is prescribed for intractable childhood epilepsy.


The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
C. G. Costa, L. Dorland, U. Holwerda, I. Tavares de Almeida, B.-T. Poll-The, C. Jakobs, and M. Duran
Simultaneous analysis of plasma free fatty acids and their 3-hydroxy analogs in fatty acid ß-oxidation disorders
Clin. Chem., March 1, 1998; 44(3): 463 - 471.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
K. P. Sucher
Medium Chain Triglycerides: A Review of Their Enteral Use in Clinical Nutrition
Nutr Clin Pract, June 1, 1986; 1(3): 146 - 150.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the American Association for Clinical Chemistry.